Symbols / KLTO
KLTO Chart
About
Klotho Neurosciences, Inc. develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. Its lead gene therapy product candidates consist of KLTO-101 for the treatment or prevention of Alzheimer's disease; and KLTO-202, a gene therapy product for treatment and prevention of Lou Gehrig's disease. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. Klotho Neurosciences, Inc. is based in Omaha, Nebraska.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Biotechnology | Market Cap | 26.02M |
| Enterprise Value | 18.67M | Income | -11.29M | Sales | — |
| Book/sh | 0.14 | Cash/sh | 0.10 | Dividend Yield | — |
| Payout | 0.00% | Employees | 3 | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | 2.54 | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | 82.76 |
| Current Ratio | 83.69 | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | -0.30 | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | — | ROA | -71.63% |
| ROE | -198.28% | ROIC | — | Gross Margin | 0.00% |
| Oper. Margin | 0.00% | Profit Margin | 0.00% | Shs Outstand | 72.54M |
| Shs Float | 66.18M | Short Float | 1.65% | Short Ratio | 1.54 |
| Short Interest | — | 52W High | 3.91 | 52W Low | 0.11 |
| Beta | 2.48 | Avg Volume | 690.60K | Volume | 8.09M |
| Target Price | — | Recom | None | Prev Close | $0.41 |
| Price | $0.36 | Change | -12.51% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$0.36
Latest analyst target
3. DCF / Fair value
$-1.46
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.36
Low
—
High
—
Mean
—
- AI-powered Klotho Clock aims to read biological age from a blood test - Stock Titan ue, 24 Feb 2026 13
- Klotho Neurosciences, Inc. (KLTO) has officially signed a securities purchase agreement. According to the latest documents submitted to the U.S. Securities and Exchange Commission (SEC), the company plans to issue a total of 34.6 million shares of common - Bitget ue, 24 Feb 2026 11
- Klotho Neurosciences Raises $7.75M at $0.2243/Share, Issues Five-Year Warrants - TradingView ue, 24 Feb 2026 11
- Klotho Neurosciences: What’s Behind The Nine-Fold Rise In KLTO Stock? - Forbes ue, 10 Jun 2025 07
- Klotho Neurosciences enters agreement to sell Series C preferred stock to Sigma9 Capital - Investing.com Mon, 08 Dec 2025 08
- KLOTHO NEUROSCIENCES (KLTO) ANNOUNCES MUTUAL TERMINATION OF SHARE EXCHANGE AGREEMENT WITH SKYBELL TECHNOLOGIES (SKYBELL), TO CONTINUE ITS FOCUS ON THERAPEUTICS AND LONGEVITY PROGRAMS - PR Newswire Wed, 18 Jun 2025 07
- What's Happening With Klotho Neurosciences Stock? - Nasdaq Wed, 11 Jun 2025 07
- Klotho Neurosciences Shareholders Approve Reverse Stock Split - TipRanks ue, 17 Feb 2026 23
- Klotho Neurosciences Stock Skyrockets On Anti-Aging Gene Therapy Breakthrough: Retail Traders Over The Moon - Stocktwits ue, 10 Jun 2025 02
- 2.1B aging population by 2050: Klotho Lets LOI with Turn Expire, Refocuses on Klotho Pipeline - Stock Titan ue, 07 Oct 2025 07
- Klotho Neurosciences, Inc. Regains Full Compliance with NASDAQ Minimum Closing Bid Price and Stockholder Equity Rules - PR Newswire Wed, 16 Jul 2025 07
- Klotho Neurosciences stock soars after FDA grants orphan drug status for ALS - Investing.com hu, 10 Jul 2025 07
- Why Is Klotho Neurosciences Stock (KLTO) Up 175% Today? - TipRanks Mon, 09 Jun 2025 07
- $300M Global Pharma Deal: Klotho Neurosciences to Acquire Revolutionary Anti-Aging Technology Platform - Stock Titan ue, 30 Sep 2025 07
- Klotho Neurosciences adjusts warrant terms - Investing.com Wed, 11 Jun 2025 07
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 200000 | — | — | Stock Award(Grant) at price 0.00 per share. | LEBLANC JEFF | Chief Financial Officer | — | 2025-08-25 00:00:00 | D |
| 1 | 14641 | — | — | Stock Award(Grant) at price 0.00 per share. | MCGARITY JON W | Director | — | 2025-08-05 00:00:00 | D |
| 2 | 153494 | — | — | Stock Award(Grant) at price 0.00 per share. | ZENTMAN SAMUEL M | Director | — | 2025-08-05 00:00:00 | D |
| 3 | 70149 | — | — | Stock Award(Grant) at price 0.00 per share. | HIRSCHMAN SHALOM Z | Director | — | 2025-08-05 00:00:00 | D |
| 4 | 537180 | — | — | Stock Award(Grant) at price 0.00 per share. | SINKULE JOSEPH | Chief Executive Officer | — | 2025-08-05 00:00:00 | D |
| 5 | 156199 | — | — | Stock Award(Grant) at price 0.00 per share. | LEBLANC JEFF | Chief Financial Officer | — | 2025-08-05 00:00:00 | D |
| 6 | 342136 | 725162 | — | Sale at price 2.05 - 2.53 per share. | CHARDAN MONTEREY INVESTMENTS LLC | Beneficial Owner of more than 10% of a Class of Security | — | 2024-07-02 00:00:00 | D |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.00 | 0.00 | 0.00 | 0.00 |
| NormalizedEBITDA | -5.79M | -631.24K | -574.23K | -1.11M |
| TotalUnusualItems | -1.96K | |||
| TotalUnusualItemsExcludingGoodwill | -1.96K | |||
| NetIncomeFromContinuingOperationNetMinorityInterest | -6.15M | -707.46K | -598.59K | -1.11M |
| EBITDA | -5.79M | -631.24K | -574.23K | -1.11M |
| EBIT | -5.79M | -631.24K | -574.23K | -1.11M |
| NetInterestIncome | -356.60K | -76.21K | -24.37K | 0.00 |
| InterestExpense | 356.60K | 76.21K | 24.37K | 0.00 |
| NormalizedIncome | -6.15M | -707.46K | -598.59K | -1.11M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -6.15M | -707.46K | -598.59K | -1.11M |
| TotalExpenses | 5.54M | 631.32K | 574.37K | 1.11M |
| TotalOperatingIncomeAsReported | -5.54M | -631.32K | -574.37K | -1.11M |
| DilutedAverageShares | 19.25M | 1.04B | 1.04B | 1.04B |
| BasicAverageShares | 19.25M | 1.04B | 1.04B | 1.04B |
| DilutedEPS | -0.32 | -0.00 | -0.00 | -0.00 |
| BasicEPS | -0.32 | -0.00 | -0.00 | -0.00 |
| DilutedNIAvailtoComStockholders | -6.15M | -707.46K | -598.59K | -1.11M |
| NetIncomeCommonStockholders | -6.15M | -707.46K | -598.59K | -1.11M |
| NetIncome | -6.15M | -707.46K | -598.59K | -1.11M |
| NetIncomeIncludingNoncontrollingInterests | -6.15M | -707.46K | -598.59K | -1.11M |
| NetIncomeContinuousOperations | -6.15M | -707.46K | -598.59K | -1.11M |
| TaxProvision | 0.00 | 0.00 | ||
| PretaxIncome | -6.15M | -707.46K | -598.59K | -1.11M |
| OtherIncomeExpense | -253.53K | 78.00 | 147.00 | 44.00 |
| OtherNonOperatingIncomeExpenses | -251.57K | 78.00 | 147.00 | 44.00 |
| GainOnSaleOfSecurity | -1.96K | |||
| NetNonOperatingInterestIncomeExpense | -356.60K | -76.21K | -24.37K | 0.00 |
| InterestExpenseNonOperating | 356.60K | 76.21K | 24.37K | 0.00 |
| OperatingIncome | -5.54M | -631.32K | -574.37K | -1.11M |
| OperatingExpense | 5.54M | 631.32K | 574.37K | 1.11M |
| SellingGeneralAndAdministration | 5.54M | 631.32K | 574.37K | 1.11M |
| GeneralAndAdministrativeExpense | 5.54M | 631.32K | 574.37K | 1.11M |
| OtherGandA | 2.89M | 631.32K | 572.97K | 287.92K |
| SalariesAndWages | 2.65M | 0.00 | 1.40K | 821.15K |
| TotalRevenue | 0.00 | 0.00 | 0.00 | 0.00 |
| OperatingRevenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| OrdinarySharesNumber | 27.08M | 15.13M | 15.13M | 15.13M |
| ShareIssued | 27.08M | 15.13M | 15.13M | 15.13M |
| NetDebt | 208.01K | 1.46M | 1.27M | |
| TotalDebt | 271.75K | 1.47M | 1.35M | |
| TangibleBookValue | -1.11M | -1.61M | -1.03M | 288.88K |
| InvestedCapital | 1.46M | 2.04M | 2.53M | 1.03M |
| WorkingCapital | -1.09M | -1.61M | -1.03M | 289.38K |
| NetTangibleAssets | -1.11M | -1.61M | -1.03M | 289.38K |
| CommonStockEquity | 1.19M | 571.72K | 1.18M | 1.03M |
| PreferredStockEquity | 505.00 | 505.00 | ||
| TotalCapitalization | 1.19M | 571.72K | 1.18M | 1.03M |
| TotalEquityGrossMinorityInterest | 1.19M | 571.72K | 1.18M | 1.03M |
| StockholdersEquity | 1.19M | 571.72K | 1.18M | 1.03M |
| RetainedEarnings | -10.56M | -3.92M | -3.22M | -2.62M |
| AdditionalPaidInCapital | 11.75M | 4.49M | 3.54M | 3.54M |
| CapitalStock | 2.71K | 1.51K | 856.39K | 104.99K |
| CommonStock | 2.71K | 1.51K | 855.89K | 104.49K |
| PreferredStock | 0.00 | 0.00 | 505.00 | 505.00 |
| TotalLiabilitiesNetMinorityInterest | 1.27M | 1.62M | 1.36M | 15.13K |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 24.49K | 0.00 | 0.00 | 0.00 |
| DerivativeProductLiabilities | 24.49K | 0.00 | ||
| CurrentLiabilities | 1.25M | 1.62M | 1.36M | 15.13K |
| CurrentDebtAndCapitalLeaseObligation | 271.75K | 1.47M | 1.35M | |
| CurrentDebt | 271.75K | 1.47M | 1.35M | |
| OtherCurrentBorrowings | 135.00K | |||
| CurrentNotesPayable | 271.75K | 1.33M | 1.35M | 0.00 |
| PayablesAndAccruedExpenses | 975.78K | 153.72K | 12.76K | 15.13K |
| CurrentAccruedExpenses | 912.10K | 2.46K | 4.74K | 0.00 |
| Payables | 63.69K | 151.26K | 8.01K | 15.13K |
| AccountsPayable | 63.69K | 151.26K | 8.01K | 15.13K |
| TotalAssets | 2.46M | 2.19M | 2.54M | 1.04M |
| TotalNonCurrentAssets | 2.30M | 2.19M | 2.21M | 736.98K |
| GoodwillAndOtherIntangibleAssets | 2.30M | 2.19M | 2.21M | 736.98K |
| OtherIntangibleAssets | 2.30M | 2.19M | 2.21M | 736.98K |
| CurrentAssets | 157.81K | 6.65K | 329.54K | 304.52K |
| PrepaidAssets | 94.07K | 3.84K | 3.67K | 3.67K |
| Receivables | 250.00K | 0.00 | ||
| DuefromRelatedPartiesCurrent | 250.00K | 0.00 | ||
| CashCashEquivalentsAndShortTermInvestments | 63.74K | 2.81K | 75.87K | 300.85K |
| CashAndCashEquivalents | 63.74K | 2.81K | 75.87K | 300.85K |
| CashFinancial | 63.74K | 2.81K | 75.87K | 300.85K |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -3.07M | -460.80K | -724.98K | -284.02K |
| RepurchaseOfCapitalStock | -120.00K | 0.00 | ||
| IssuanceOfDebt | 2.18M | 0.00 | ||
| IssuanceOfCapitalStock | 295.00K | 0.00 | 750.00K | 250.00K |
| CapitalExpenditure | -123.50K | -13.89K | -125.41K | |
| InterestPaidSupplementalData | 2.46K | 78.50K | 19.62K | 0.00 |
| IncomeTaxPaidSupplementalData | 551.59K | 0.00 | 0.00 | 0.00 |
| EndCashPosition | 63.74K | 2.81K | 75.87K | 300.85K |
| BeginningCashPosition | 2.81K | 75.87K | 300.85K | 334.87K |
| ChangesInCash | 60.93K | -73.06K | -224.98K | -34.02K |
| FinancingCashFlow | 3.13M | 350.00K | 500.00K | 250.00K |
| CashFlowFromContinuingFinancingActivities | 3.13M | 350.00K | 500.00K | 250.00K |
| NetOtherFinancingCharges | 778.94K | 350.00K | 500.00K | 250.00K |
| NetCommonStockIssuance | 175.00K | 0.00 | 750.00K | 250.00K |
| CommonStockPayments | -120.00K | 0.00 | ||
| CommonStockIssuance | 295.00K | 0.00 | 750.00K | 250.00K |
| NetIssuancePaymentsOfDebt | 2.18M | 0.00 | ||
| NetShortTermDebtIssuance | 2.18M | 0.00 | ||
| ShortTermDebtIssuance | 2.18M | 0.00 | ||
| InvestingCashFlow | -123.50K | 23.85K | -125.41K | 0.00 |
| CashFlowFromContinuingInvestingActivities | -123.50K | 23.85K | -125.41K | 0.00 |
| NetIntangiblesPurchaseAndSale | -123.50K | 23.85K | -125.41K | 0.00 |
| SaleOfIntangibles | 0.00 | 37.74K | ||
| PurchaseOfIntangibles | -123.50K | -13.89K | -125.41K | 0.00 |
| OperatingCashFlow | -2.95M | -446.92K | -599.57K | -284.02K |
| CashFlowFromContinuingOperatingActivities | -2.95M | -446.92K | -599.57K | -284.02K |
| ChangeInWorkingCapital | 150.57K | 260.54K | -2.38K | 3.85K |
| ChangeInOtherCurrentLiabilities | 60.02K | 0.00 | ||
| ChangeInPayablesAndAccruedExpense | 180.78K | 260.71K | -2.38K | 2.24K |
| ChangeInAccruedExpense | 1.06M | -2.28K | 4.74K | 0.00 |
| ChangeInPayable | -883.68K | 263.00K | -7.12K | 2.24K |
| ChangeInAccountPayable | -187.57K | 104.00K | -7.12K | -12.90K |
| ChangeInTaxPayable | -568.11K | 0.00 | ||
| ChangeInIncomeTaxPayable | -568.11K | 0.00 | ||
| ChangeInPrepaidAssets | -90.23K | -173.00 | 0.00 | 1.61K |
| OtherNonCashItems | 391.75K | |||
| StockBasedCompensation | 2.65M | 0.00 | 1.40K | 821.15K |
| AssetImpairmentCharge | 10.00K | 0.00 | ||
| OperatingGainsLosses | 1.96K | |||
| GainLossOnInvestmentSecurities | 1.96K | |||
| NetIncomeFromContinuingOperations | -6.15M | -707.46K | -598.59K | -1.11M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for KLTO
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|